Uncover key drivers, emerging technologies, and competitive movements shaping the worker heat stress monitoring wearable market from 2026–2035 with trusted insights from The Business Research Company
What are the forecasted starting (2026) and ending (2030) market sizes for the Point-of-Care Technology Market?
The point-of-care technology market size has experienced significant expansion in recent years. It is forecast to rise from $43.21 billion in 2025 to $47.41 billion in 2026, reflecting a compound annual growth rate (CAGR) of 9.7%. The market’s growth during the historical period was primarily influenced by the reliance on centralized laboratory testing, insufficient access to rapid diagnostics in remote locations, the increasing prevalence of infectious diseases, growing volumes of hospital patients, and the initial implementation of basic point-of-care devices.
The point-of-care technology market size is expected to show substantial growth in the next few years. It is predicted to reach $67.94 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 9.4%. The expansion during this forecast period can be attributed to advancements in microfluidics and PCR technologies, the increasing occurrence of chronic and lifestyle diseases, the growth of homecare and decentralized healthcare models, rising healthcare digitization, and favorable regulatory frameworks for rapid diagnostics. Major trends anticipated for this period include a heightened demand for rapid diagnostic testing at the point of care, an increasing adoption of home-based and remote testing solutions, the development of portable and handheld diagnostic devices, the broadening of infectious disease and chronic disease testing, and an improved focus on ease of use and faster turnaround times.
Access Your Free Sample Report for In-Depth Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=27390&type=smp
What Drivers Are Supporting Technological Adoption In The Point-of-Care Technology Market?
The increasing occurrence of chronic illnesses is anticipated to fuel the expansion of the point-of-care technology market moving forward. These enduring health conditions persist over extended periods and typically necessitate continuous management and lifestyle modifications. Sedentary lifestyles are contributing to the rise in chronic illnesses, as prolonged sitting and insufficient physical activity heighten the risk of developing conditions such as heart disease and diabetes. Point-of-care technology aids in managing chronic illnesses by providing rapid, on-site diagnostic testing, making it well-suited for clinics, homes, and remote care settings. It helps reduce delays in treatment by offering real-time results, thereby enhancing patient monitoring and overall healthcare convenience. For instance, in June 2024, the National Health Service, a UK-based government department, reported that 3,615,330 individuals registered with a general practitioner (GP) were diagnosed with non-diabetic hyperglycemia or pre-diabetes in 2023, which was an 18% increase from 3,065,825 cases in 2022. Consequently, the rising prevalence of chronic illnesses is stimulating the growth of the point-of-care technology market.
Which Segments Are Contributing To The Growth Of The Point-of-Care Technology Market?
The point-of-care technology market covered in this report is segmented –
1) By Product Type: Diagnostics Devices, Monitoring Devices, Therapeutic Devices, Data Management Systems
2) By Ownership Model: Standalone Solutions, Integrated Solutions, Cloud-Based Solutions
3) By Technology: Microfluidics, Polymerase Chain Reaction (PCR), Immunoassays
4) By Application: Infectious Disease Testing, Glucose Monitoring, Cardiometabolic Monitoring, Pregnancy And Fertility Testing, Other Applications
5) By End-User: Hospitals, Clinics, Homecare Settings, Ambulatory Surgical Centers
Subsegments:
1) By Diagnostics Devices: Blood Glucose Monitoring Devices, Infectious Disease Testing Devices, Cardiac Marker Testing Devices, Coagulation Testing Devices, Pregnancy And Fertility Testing Devices, Urinalysis Testing Devices, Hematology Testing Devices, Cholesterol Testing Devices
2) By Monitoring Devices: Vital Signs Monitoring Devices, Continuous Glucose Monitoring Devices, Cardiac Monitoring Devices, Respiratory Monitoring Devices
3) By Therapeutic Devices: Insulin Delivery Devices, Nebulizers, Dialysis Machines, Infusion Pumps
4) By Data Management Systems: Point Of Care (POC) Data Integration Systems, Point Of Care (POC) Middleware Solutions, Point Of Care (POC) Data Analytics Platforms
What Trends Are Expected To Impact The Competitive Landscape Of The Point-of-Care Technology Market?
Leading companies within the point-of-care technology market are concentrating on developing technologically advanced solutions, specifically AI-powered diagnostic platforms, to enhance accuracy, speed, and accessibility in disease identification. These AI-powered diagnostic platforms are sophisticated systems that harness artificial intelligence for the rapid analysis of medical data, facilitating real-time, on-site testing for critical conditions such as cancer. For example, in February 2025, Avitia Inc., a Canada-based point-of-care diagnostics company, unveiled an AI-powered platform designed for swift and on-site cancer testing. This platform merges machine learning algorithms with portable diagnostic devices, enabling healthcare providers to perform fast, precise cancer screening outside conventional laboratory settings. This innovation shortens turnaround times, boosts early detection, and reduces the necessity for complex infrastructure, thereby making advanced diagnostics more attainable in remote or underserved areas.
Who Are The Core Companies Influencing Trends In The Point-of-Care Technology Market?
Major companies operating in the point-of-care technology market are F. Hoffmann-La Roche AG, Thermo Fisher Scientific Inc., Abbott Laboratories, Danaher Corporation, Siemens Healthineers AG, Hologic Inc., bioMérieux SA, Quidel Corporation, Sysmex Corporation, Cepheid Inc., Radiometer Medical ApS, Nova Biomedical, Sekisui Diagnostics LLC, Abaxis Inc., BHR Biosynex, EKF Diagnostics Holdings plc, Acon Laboratories Inc., Trinity Biotech plc, Chembio Diagnostics Inc., Arkray Inc., Orchard Software Corporation, Point of Care Biomedical Private Limited
Access The Complete Report For Deeper Market Insights:
https://www.thebusinessresearchcompany.com/report/point-of-care-technology-global-market-report
Which Region Is Expected To Experience The Fastest Growth In The Point-of-Care Technology Market?
North America was the largest region in the point-of-care technology market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the point-of-care technology market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request Your Customized Point-of-Care Technology Market Research Report for Competitive Advantage:
https://www.thebusinessresearchcompany.com/customise?id=27390&type=smp
Browse Through More Reports Similar to the Global Point-of-Care Technology Market 2026, By The Business Research Company
Aerospace Adhesives And Sealants Global Market Report 2026
Surgical Sealants And Adhesives Market 2026
https://www.thebusinessresearchcompany.com/report/surgical-sealants-and-adhesives-market
Dental Adhesives And Sealants Global Market Report 2026
https://www.thebusinessresearchcompany.com/report/dental-adhesives-and-sealants-global-market-report
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company